DutaFabs are engineered therapeutic Fab fragments that can bind two targets simultaneously

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-021-20949-3
Affiliations:
4
Authors:
12
Institutions Authors Share
Roche Deutschland Holding GmbH, Germany
9.000000
0.75
SARomics Biostructures AB, Sweden
2.000000
0.17
F. Hoffmann-La Roche Ltd., Switzerland
1.000000
0.08